Literature DB >> 28434164

Microglia Loss Contributes to the Development of Major Depression Induced by Different Types of Chronic Stresses.

Lijuan Tong1,2, Yu Gong1,2, Peng Wang1,2, Wenfeng Hu1,2, Jili Wang1,2, Zhuo Chen3, Wei Zhang1,2, Chao Huang4,5.   

Abstract

Recently, the loss and dystrophy of hippocampal microglia induced by chronic unpredictable stress (CUS) has been reported to mediate the development of major depression in mice whose microglial cells were labeled with enhanced green fluorescent protein-conjuncted-CX3C receptor type 1. However, whether this happens in endogenous microglia with no genetic intervention remains unclear. Here, we addressed this issue in mice treated with different types of chronic stresses, including the CUS, chronic restraint stress (CRS) and chronic social defeat stress (CSDS). Results showed that the cellular numbers, process lengths, soma areas and activation markers of endogenous hippocampal but not cortical microglia, were markedly reduced by CUS, CRS and CSDS treatment. Administration of mice with two classical stimulators of microglia, lipopolysaccharide (LPS) or macrophage colony-stimulating factor (M-CSF), reversed the CUS-, CRS- and CSDS-induced reductions in endogenous hippocampal microglial numbers, and also improved the CUS-, CRS- or CSDS-induced behavioral abnormalities, including the increases in the immobile time in the forced swimming test and tail suspension test, the inhibition of sucrose preference, and the decrease in the time spent in the center of open field. Furthermore, inhibition of the initial activation of hippocampal microglia by minocycline pretreatment also reversed the reduction in hippocampal microglial numbers as well as the behavioral abnormalities induced by CUS, CRS and CSDS treatment. These results provide compelling evidences to show that different types of chronic stresses can trigger the loss of endogenous hippocampal microglia and restoration of microglial numbers may have therapeutic values in major depression.

Entities:  

Keywords:  LPS; M-CSF; Major depression; Microglia; Minocycline

Mesh:

Substances:

Year:  2017        PMID: 28434164     DOI: 10.1007/s11064-017-2270-4

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  51 in total

1.  Glial dysfunction in the mouse habenula causes depressive-like behaviors and sleep disturbance.

Authors:  Wanpeng Cui; Hiroaki Mizukami; Michiko Yanagisawa; Tomomi Aida; Masatoshi Nomura; Yoshikazu Isomura; Ryoichi Takayanagi; Keiya Ozawa; Kohichi Tanaka; Hidenori Aizawa
Journal:  J Neurosci       Date:  2014-12-03       Impact factor: 6.167

2.  Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction.

Authors:  Mingchao Liu; Juan Li; Peng Dai; Fang Zhao; Gang Zheng; Jinfei Jing; Jiye Wang; Wenjing Luo; Jingyuan Chen
Journal:  Stress       Date:  2015-01-08       Impact factor: 3.493

3.  Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.

Authors:  J A Cobb; K O'Neill; J Milner; G J Mahajan; T J Lawrence; W L May; J Miguel-Hidalgo; G Rajkowska; C A Stockmeier
Journal:  Neuroscience       Date:  2015-12-30       Impact factor: 3.590

Review 4.  The future of depression psychopharmacology.

Authors:  R H Belmaker
Journal:  CNS Spectr       Date:  2008-08       Impact factor: 3.790

5.  Dynamic microglial alterations underlie stress-induced depressive-like behavior and suppressed neurogenesis.

Authors:  T Kreisel; M G Frank; T Licht; R Reshef; O Ben-Menachem-Zidon; M V Baratta; S F Maier; R Yirmiya
Journal:  Mol Psychiatry       Date:  2013-12-17       Impact factor: 15.992

6.  Pifithrin-μ Attenuates Acute Sickness Response to Lipopolysaccharide in C57BL/6J Mice.

Authors:  Rongping Zhang; Jili Wang; Yanling Hu; Xu Lu; Bo Jiang; Wei Zhang; Chao Huang
Journal:  Pharmacology       Date:  2016-02-17       Impact factor: 2.547

7.  Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.

Authors:  Vincent Boissonneault; Mohammed Filali; Martine Lessard; Jane Relton; Gordon Wong; Serge Rivest
Journal:  Brain       Date:  2009-01-17       Impact factor: 13.501

8.  Antidepressant-like actions of minocycline combined with several glutamate antagonists.

Authors:  Miguel Molina-Hernández; Norma Patricia Tellez-Alcántara; Julian Pérez-García; Jorge Ivan Olivera-Lopez; M Teresa Jaramillo-Jaimes
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-09-14       Impact factor: 5.067

9.  Deletion of CREB-regulated transcription coactivator 1 induces pathological aggression, depression-related behaviors, and neuroplasticity genes dysregulation in mice.

Authors:  Lionel Breuillaud; Clara Rossetti; Elsa M Meylan; Christophe Mérinat; Olivier Halfon; Pierre J Magistretti; Jean-René Cardinaux
Journal:  Biol Psychiatry       Date:  2012-05-15       Impact factor: 13.382

10.  Cerebral and peripheral changes occurring in nitric oxide (NO) synthesis in a rat model of sleeping sickness: identification of brain iNOS expressing cells.

Authors:  Donia Amrouni; Sabine Gautier-Sauvigné; Anne Meiller; Philippe Vincendeau; Bernard Bouteille; Alain Buguet; Raymond Cespuglio
Journal:  PLoS One       Date:  2010-02-16       Impact factor: 3.240

View more
  22 in total

Review 1.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

Review 2.  Dopaminergic impact of cART and anti-depressants on HIV neuropathogenesis in older adults.

Authors:  Stephanie M Matt; Peter J Gaskill
Journal:  Brain Res       Date:  2019-08-21       Impact factor: 3.252

Review 3.  Microglia, Lifestyle Stress, and Neurodegeneration.

Authors:  Charlotte Madore; Zhuoran Yin; Jeffrey Leibowitz; Oleg Butovsky
Journal:  Immunity       Date:  2020-01-07       Impact factor: 31.745

Review 4.  Colony stimulating factors in the nervous system.

Authors:  Violeta Chitu; Fabrizio Biundo; E Richard Stanley
Journal:  Semin Immunol       Date:  2021-11-04       Impact factor: 11.130

5.  Microglia and their LAG3 checkpoint underlie the antidepressant and neurogenesis-enhancing effects of electroconvulsive stimulation.

Authors:  Neta Rimmerman; Hodaya Verdiger; Hagar Goldenberg; Lior Naggan; Elad Robinson; Ewa Kozela; Sivan Gelb; Ronen Reshef; Karen M Ryan; Lily Ayoun; Ron Refaeli; Einat Ashkenazi; Nofar Schottlender; Laura Ben Hemo-Cohen; Claudia Pienica; Maayan Aharonian; Eyal Dinur; Koby Lazar; Declan M McLoughlin; Ayal Ben Zvi; Raz Yirmiya
Journal:  Mol Psychiatry       Date:  2021-10-14       Impact factor: 15.992

6.  Comparison of inflammatory and behavioral responses to chronic stress in female and male mice.

Authors:  Eva M Medina-Rodriguez; Kenner C Rice; Richard S Jope; Eléonore Beurel
Journal:  Brain Behav Immun       Date:  2022-09-01       Impact factor: 19.227

7.  Acupuncture Ameliorates Depressive Behaviors by Modulating the Expression of Hippocampal Iba-1 and HMGB1 in Rats Exposed to Chronic Restraint Stress.

Authors:  Lu Chen; Huili Jiang; Tuya Bao; Yu Wang; Hong Meng; Yang Sun; Pengfei Liu; Songxiao Quan; Wenshan Li; Simin Qi; Xiujun Ren
Journal:  Front Psychiatry       Date:  2022-06-06       Impact factor: 5.435

Review 8.  Immunoneuropsychiatry - novel perspectives on brain disorders.

Authors:  Marion Leboyer; Frauke Zipp; Katrin Pape; Ryad Tamouza
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

Review 9.  Microglia in depression: current perspectives.

Authors:  Xiaoning Jia; Zhihua Gao; Hailan Hu
Journal:  Sci China Life Sci       Date:  2020-10-14       Impact factor: 6.038

Review 10.  Microglial Over-Activation by Social Defeat Stress Contributes to Anxiety- and Depressive-Like Behaviors.

Authors:  Dirson J Stein; Mailton F Vasconcelos; Lucas Albrechet-Souza; Keila M M Ceresér; Rosa M M de Almeida
Journal:  Front Behav Neurosci       Date:  2017-10-24       Impact factor: 3.558

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.